Analgesics in France
Description
Sales of analgesic have seen stronger growth in 2025 compared to 2024, in current value terms. This is linked in part to a more severe cold and flu season in winter 2024/2025, with consumers’ still being impacted by weaker immune systems in the post-pandemic period. France saw the circulation of three flu viruses as well as a new strain of COVID-19, which put a strain on the public health system as well as driving demand for analgesics as consumers looked for relief from the symptoms.
Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report??
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report??
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
25 Pages
- Analgesics in France
- Euromonitor International
- October 2025
- List Of Contents And Tables
- ANALGESICS IN FRANCE
- KEY DATA FINDINGS
- 2025 DEVELOPMENTS
- Analgesics continues to report healthy growth in 2025
- Doliprane remains on top while ibuprofen brands suffer from negative media articles
- Pharmacies and e-commerce monopolise distribution despite campaign to ease restrictions
- PROSPECTS AND OPPORTUNITIES
- Analgesics set for continued growth despite the challenges facing the market
- Fears of shortages over as France looks to invest in local production
- Herbal/traditional products could gain ground while the distribution landscape will remain under debate
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2020-2025
- Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
- Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
- Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
- Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
- CONSUMER HEALTH IN FRANCE
- EXECUTIVE SUMMARY
- Consumer Health in 2025: The big picture
- Key trends in 2025
- Competitive landscape
- Channel developments
- What next for Consumer Health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
- Table 8 Life Expectancy at Birth 2020-2025
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2020-2025
- Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
- Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
- Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
- Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
- Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2024-2025
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

